South Korea stepping up fight against TB, CBS News reports

NewsGuard 100/100 Score

CBS News examines the fight against tuberculosis (TB) in South Korea, which "has the highest incidence rate of tuberculosis among the world's wealthiest countries, nations [that] belong to the 34-member Organization for Economic Cooperation and Development (OECD)." The news service continues, "In 2010, South Korea's incidence rate of tuberculosis was 97 out of 100,000, according to the World Health Organization (WHO), while the mortality rate of TB was 5.4 out of 100,000. (In the U.S., the incidence rate was 4.1 and the mortality rate was 0.18 during the same time period.)"

Many public health officials say the high rate of TB is a "legacy" of the Korean War, but the nation "made great strides in detecting and treating tuberculosis patients from the 1960s to the early 1990s," the news service notes. The fight against the disease waned in 1995, but "[l]ast year, the South Korean health ministry quadrupled the annual budget for its tuberculosis program from previous years to 45 billion won ($39.9 million)," according to CBS News. However, "[e]xperts agree that the long-term public health goal of reducing the incidence rate of TB in South Korea by a quarter by 2020, and eliminating it completely by 2030, are infeasible," the news service writes (2/21).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Association of estrogen-containing menopause hormonal therapy with COVID-19 mortality